Table 3. Cox proportional hazards regression for 5hmC and other prognostic factors.
Univariable | Multivariable | |||||
---|---|---|---|---|---|---|
n | HR(95% CI) | P value | HR(95% CI) | P value | ||
MFSa | ||||||
5hmC | 37 | Score 0 | 1 | 1 | ||
102 | Score 1-2 | 0.40 (0.23-0.69) | 0.001 | 0.50 (0.27-0.93) | 0.02 | |
61 | Score 3-4 | 0.10 (0.04-0.24) | 5.0x10-7 | 0.16 (0.06-0.43) | 0.0002 | |
Age | 200 | Years | 1.02 (1.01-1.04) | 0.007 | 0.99 (0.98-1.01) | 0.47 |
Sex | 99 | Female | 1 | |||
101 | Male | 1.08 (0.65-1.78) | 0.78 | 1.34 (0.75-2.38) | 0.32 | |
Site | 109 | Central | 1 | 1 | ||
91 | Peripheral | 1.30 (0.79-2.15) | 0.30 | 1.15 (0.63-2.09) | 0.65 | |
Breslow depth | 200 | millimetres | 1.10 (1.07-1.13) | 4.24x10-12 | 1.01 (0.97-1.06) | 0.60 |
Mitotic rate | 200 | Mitoses/mm2 | 1.13 (1.10-1.16) | <2x10-16 | 1.05 (1.01-1.09) | 0.007 |
Ulcer | 154 | No | 1 | 1 | ||
46 | Yes | 8.64 (5.13-14.53) | 4.44x10-16 | 5.00 (2.43-10.18) | 0.00001 | |
Microsatellite | 194 | No | 1 | 1 | ||
6 | Yes | 3.53 (1.10-11.33) | 0.03 | 1.18 (0.35-3.98) | 0.79 | |
MSSb | ||||||
5hmC | 37 | Score 0 | 1 | 1 | ||
102 | Score 1-2 | 0.33 (0.18-0.60) | 0.0003 | 0.43 (0.21-0.86) | 0.02 | |
61 | Score 3-4 | 0.09 (0.03-0.24) | 1.67x10-6 | 0.19 (0.07-0.56) | 0.002 | |
Age | 200 | Years | 1.03 (1.01-1.05) | 0.006 | 1.00 (0.98-1.02) | 0.96 |
Sex | 99 | Female | 1 | |||
101 | Male | 1.21 (0.70-2.10) | 0.50 | 1.56 (0.83-2.95) | 0.17 | |
Site | 109 | Central | 1 | |||
91 | Peripheral | 1.52 (0.87-2.64) | 0.14 | 1.51 (0.77-2.96) | 0.23 | |
Breslow depth | 200 | millimetres | 1.12 (1.09-1.15) | 9.44x10-15 | 1.02 (0.98-1.07) | 0.41 |
Mitotic rate | 200 | Mitoses/mm2 | 1.14 (1.11-1.17) | <2x10-16 | 1.06 (1.02-1.11) | 0.007 |
Ulcer | 154 | No | 1 | |||
46 | Yes | 10.41 (5.87-18.48) | 1.22x10-15 | 5.16 (2.34-11.40) | 0.00005 | |
Microsatellite | 194 | No | 1 | |||
6 | Yes | 4.66 (1.44-15.09) | 0.01 | 1.86 (0.54-6.47) | 0.33 | |
OSc | ||||||
5hmC | 37 | Score 0 | 1 | 1 | ||
102 | Score 1-2 | 0.46 (0.28-0.77) | 0.003 | 0.55 (0.31-0.98) | 0.04 | |
61 | Score 3-4 | 0.16 (0.08-0.32) | 6.02x10-7 | 0.10 (0.36-0.72) | 0.01 | |
Age | 200 | Years | 1.05 (1.03-1.07) | 7.43x10-8 | 1.03 (1.01-1.04) | 0.009 |
Sex | 99 | Female | 1 | |||
101 | Male | 1.43 (0.92-2.24) | 0.11 | 1.64 (0.97-2.79) | 0.07 | |
Site | 109 | Central | 1 | |||
91 | Peripheral | 1.12 (0.72-1.74) | 0.62 | 1.11 (0.64-1.92) | 0.72 | |
Breslow depth | 200 | millimetres | 1.12 (1.09-1.14) | <2x10-16 | 1.03 (0.99-1.07) | 0.19 |
Mitotic rate | 200 | Mitoses/mm2 | 1.13 (1.11-1.16) | <2x10-16 | 1.08 (1.04-1.12) | 0.00001 |
Ulcer | 154 | No | 1 | |||
46 | Yes | 6.65 (4.26-10.4) | <2x10-16 | 2.15 (1.17-3.97) | 0.01 | |
Microsatellite | 194 | No | 1 | |||
6 | Yes | 6.84 (2.94-15.9) | 7.92x10-6 | 2.70 (1.10-6.59) | 0.03 | |
Metastasis-free survival.
Melanoma-specific survival.
Overall survival.